This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradford, P. A.
Right arrow Articles by O'Connell, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradford, P. A.
Right arrow Articles by O'Connell, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2005, p. 3903-3909, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3903-3909.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test Method

Patricia A. Bradford,1* Peter J. Petersen,1 Mairead Young,2 C. Hal Jones,1 Mark Tischler,2 and John O'Connell1

Infectious Disease Discovery Research,1 Chemical and Screening Sciences, Wyeth Research, Pearl River, New York2

Received 18 March 2005/ Returned for modification 3 May 2005/ Accepted 21 June 2005

Tigecycline is a broad-spectrum glycylcycline antibiotic with activity against not only susceptible gram-positive and gram-negative pathogens but also strains that are resistant to many other antibiotics. In the process of determining quality control (QC) limits for the American Type Culture Collection reference strains for tigecycline, a number of inconsistencies in MICs were encountered which appeared to be related to the age of the Mueller-Hinton broth (MHB) medium used in the MIC testing. The objective of this study was to determine the cause of the discrepant MIC results between fresh and aged MHB. The MICs of tigecycline were determined in MHB that was either prepared fresh (<12 h old), prepared and stored at 4°C, stored at room temperature, stored anaerobically, or supplemented with the biocatalytic oxygen-reducing reagent Oxyrase. When tested in fresh media, tigecycline was 2 to 3 dilutions more active against the CLSI-recommended QC strains compared to aged media (MICs of 0.03 to 0.25 and 0.12 to 0.5 µg/ml, respectively). Media aged under anaerobic conditions prior to testing or supplemented with Oxyrase resulted in MICs similar to those obtained in fresh medium (MICs of 0.03 to 0.12 and 0.03 to 0.25 µg/ml, respectively). Time-kill kinetics demonstrated a >3 log10 difference in viable growth when tigecycline was tested in fresh or Oxyrase-supplemented MHB compared to aged MHB. High-pressure liquid chromatography analysis revealed the accumulation of an early peak (oxidative by-product of tigecycline) to be 3.5% in fresh media and 25.1% in aged media after 24 h and that addition of Oxyrase prevented the accumulation of this oxidized by-product. These results suggested that the activity of tigecycline was affected by the amount of dissolved oxygen in the media. The use of fresh MHB or supplementation with Oxyrase resulted in a more standardized test method for performing MIC tests with tigecycline.

* Corresponding author. Mailing address: Wyeth Research, 401 N. Middletown Rd., Pearl River, NY 10965. Phone: (845) 602-4396. Fax: (845) 602-5671. E-mail: bradfop{at}wyeth.com.

Antimicrobial Agents and Chemotherapy, September 2005, p. 3903-3909, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3903-3909.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vaudaux, P., Fleury, B., Gjinovci, A., Huggler, E., Tangomo-Bento, M., Lew, D. P. (2009). Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 3150-3152 [Abstract] [Full Text]  
  • Nicasio, A. M., Crandon, J. L., Nicolau, D. P. (2009). In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates. Antimicrob. Agents Chemother. 53: 2756-2761 [Abstract] [Full Text]  
  • Fernandez-Mazarrasa, C., Mazarrasa, O., Calvo, J., del Arco, A., Martinez-Martinez, L. (2009). High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by Etest. J. Clin. Microbiol. 47: 827-829 [Abstract] [Full Text]  
  • Pankuch, G. A., Appelbaum, P. C. (2009). Postantibiotic Effect of Tigecycline against 14 Gram-Positive Organisms. Antimicrob. Agents Chemother. 53: 782-784 [Abstract] [Full Text]  
  • Livermore, D. M., Hope, R., Brick, G., Lillie, M., Reynolds, R., on behalf of the BSAC Working Parties on Resistanc, (2008). Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 62: ii41-ii54 [Abstract] [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Keeney, D., Ruzin, A., McAleese, F., Murphy, E., Bradford, P. A. (2008). MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61: 46-53 [Abstract] [Full Text]  
  • Clark, C. L., Kosowska-Shick, K., Ednie, L. M., Appelbaum, P. C. (2007). Capability of 11 Antipneumococcal Antibiotics To Select for Resistance by Multistep and Single-Step Methodologies. Antimicrob. Agents Chemother. 51: 4196-4201 [Abstract] [Full Text]  
  • Bolmstrom, A., Karlsson, A., Engelhardt, A., Ho, P., Petersen, P. J., Bradford, P. A., Jones, C. H. (2007). Validation and Reproducibility Assessment of Tigecycline MIC Determinations by Etest. J. Clin. Microbiol. 45: 2474-2479 [Abstract] [Full Text]  
  • Brown, S. D., Traczewski, M. M. (2007). Comparative In Vitro Antimicrobial Activity of Tigecycline, a New Glycylcycline Compound, in Freshly Prepared Medium and Quality Control. J. Clin. Microbiol. 45: 2173-2179 [Abstract] [Full Text]  
  • Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A., Noskin, G. A. (2007). In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 1621-1626 [Abstract] [Full Text]  
  • Cercenado, E., Marin, M., Sanchez-Martinez, M., Cuevas, O., Martinez-Alarcon, J., Bouza, E. (2007). In Vitro Activities of Tigecycline and Eight Other Antimicrobials against Different Nocardia Species Identified by Molecular Methods. Antimicrob. Agents Chemother. 51: 1102-1104 [Abstract] [Full Text]  
  • Jones, C. H., Tuckman, M., Howe, A. Y. M., Orlowski, M., Mullen, S., Chan, K., Bradford, P. A. (2006). Diagnostic PCR Analysis of the Occurrence of Methicillin and Tetracycline Resistance Genes among Staphylococcus aureus Isolates from Phase 3 Clinical Trials of Tigecycline for Complicated Skin and Skin Structure Infections. Antimicrob. Agents Chemother. 50: 505-510 [Abstract] [Full Text]  
  • Hope, R., Warner, M., Mushtaq, S., Ward, M. E., Parsons, T., Livermore, D. M. (2005). Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 56: 1042-1046 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»